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A B S T R A C T
Background: Exposure to crystalline silica (SiO2), in the form of quartz, tridymite or cristobalite, can cause
respiratory diseases, such as silicosis. However, the observed toxicity and pathogenicity of crystalline silica is
highly variable. This has been attributed to a number of inherent and external factors, including the presence of
impurities. In cristobalite-rich dusts, substitutions of aluminium (Al) for silicon (Si) in the cristobalite structure,
and impurities occluding the silica surface, have been hypothesised to decrease its toxicity. This hypothesis is
tested here through the characterisation and in vitro toxicological study of synthesised cristobalite with incre-
mental amounts of Al and sodium (Na) dopants.
Methods: Samples of synthetic cristobalite with incremental amounts of Al and Na impurities, and tridymite,
were produced through heating of a silica sol-gel. Samples were characterised for mineralogy, cristobalite purity
and abundance, particle size, surface area and surface charge. In vitro assays assessed the ability of the samples
to induce cytotoxicity and TNF-α production in J774 macrophages, and haemolysis of red blood cells.
Results: Al-only doped or Al+Na co-doped cristobalite contained between 1 and 4 oxide wt% Al and Na within
its structure. Co-doped samples also contained Al- and Na-rich phases, such as albite. Doping reduced cyto-
toxicity to J774 macrophages and haemolytic capacity compared to non-doped samples. Al-only doping was
more eﬀective at decreasing cristobalite reactivity than Al+Na co-doping. The reduction in the reactivity of
cristobalite is attributed to both structural impurities and a lower abundance of crystalline silica in doped
samples. Neither non-doped nor doped crystalline silica induced production of the pro-inﬂammatory cytokine
TNF-α in J774 macrophages.
Conclusions: Impurities can reduce the toxic potential of cristobalite and may help explain the low reactivity of
some cristobalite-rich dusts. Whilst further work is required to determine if these eﬀects translate to altered
pathogenesis, the results have potential implications for the regulation of crystalline silica exposures.
1. Introduction
Crystalline silica, in the form of quartz, tridymite or cristobalite, can
cause respiratory diseases when inhaled, such as silicosis (Greenberg
et al., 2007; Leung et al., 2012), and is listed as a carcinogen by the
International Agency for Research on Cancer (IARC, 1997). However,
crystalline silica toxicity has been described as ‘a variable entity’
(Donaldson and Borm, 1998), as it has variable ﬁbrogenic, mutagenic
and carcinogenic potency (Donaldson and Borm, 1998; Meldrum and
Howden, 2002; Mossman and Glenn, 2013). The variable toxicity of
crystalline silica has been attributed to both the inherent characteristics
of the silica particle and external factors that can alter the particle
surface reactivity (IARC, 1997), including the presence of impurities
(Fubini, 1998).
Quartz is the most common form of crystalline silica, however, ex-
posure to cristobalite is also common in some industries, such as the
diatomaceous earth industry where processed samples can contain up
to 85 wt% cristobalite (e.g., Bye et al., 1984, Rafnsson and
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Gunnarsdóttir, 1997). In environmental settings, substantial quantities
of cristobalite have been found in volcanic ash, such as from the 1980
Mount St Helens, USA eruption (Damby, 2012; Dollberg et al., 1986),
and the sustained eruptions of Soufrière Hills Volcano, Montserrat,
which produced volcanic ash containing up to 25 wt% cristobalite
(Horwell et al., 2014).
The open crystal structure of cristobalite, compared to quartz,
readily allows for the incorporation of other elements into the structure
through substitutions of cations into the silica tetrahedra (Deer et al.,
2013). Analyses of volcanic and diatomaceous earth cristobalite sam-
ples, by the authors, have shown that they always contain impurities. In
volcanic cristobalite, this is predominantly Al and Na (up to 4 oxide wt
% combined) (Horwell et al., 2012). In diatomaceous earth cristobalite,
Al, Fe, Na, and Ca have been observed (Nattrass et al., 2015) (up to
13 wt% combined (Nattrass, 2015)). The incorporation of these ele-
ments into the crystal structure is likely due to the substitution of Al3+
or Fe3+ for Si4+ and with interstitial Na+ or Ca2+ to balance the
charge (Deer et al., 2013).
As with quartz, toxicology studies have shown that cristobalite can
increase gene expression and cytokine release in macrophage and lung
epithelium models (Perkins et al., 2012; Barrett et al., 1999), as well as
trigger inﬂammasome activation (Peeters et al., 2014; Damby et al.,
2015). However, cristobalite exposure in pottery workers did not ap-
pear to cause any adverse eﬀects (Cherry et al., 1998), cristobalite-rich
volcanic ash has low toxicity in vitro (Damby et al., 2016; Wilson et al.,
2000) and in vivo (Cullen et al., 2002; Housley et al., 2002) and,
clinically, there is currently no evidence of chronic disease from ex-
posure to volcanic ash (Baxter et al., 2014). In diatomaceous earth
workers, the evidence is conﬂicting; a number of epidemiology studies
have attributed increased mortality (Checkoway et al., 1993), lung
cancer (Rice et al., 2001) and other lung diseases (Park et al., 2002) to
cristobalite exposure. This has been supported clinically (Hughes et al.,
1998), however, some studies of diﬀerent cohorts show no signiﬁcant
increase in lung disease (Rafnsson and Gunnarsdóttir, 1997) and opa-
cities dissimilar to those of silicosis (Harber et al., 1998; Vigliani and
Mottura, 1948). Toxicology studies have found cristobalite-rich diato-
maceous earth to have low cytotoxicity and pro-inﬂammatory potential
(Nattrass et al., 2015; Bye et al., 1984; Ghiazza et al., 2009), and no
ﬁbrotic eﬀect on rats, guinea-pigs or dogs (Wagner et al., 1968). That
epidemiology and toxicology studies of impure, occupational or natu-
rally-occurring cristobalite generally show a lower toxicity, compared
to toxicology studies of pure cristobalite powders, suggests impurities
may play a role in altering cristobalite toxicity.
It has been hypothesised that structural substitutions can inhibit the
toxicity of cristobalite in a similar way to treating the crystalline silica
surface (Horwell et al., 2012; Nattrass et al., 2015). Treatment of a
quartz surface with Al lactate or polyvinyl pyridine N-oxide (PVNO) has
been shown to dampen its cytotoxicity, haemolytic potential and ability
to damage DNA (Duﬃn et al., 2001; Knaapen et al., 2002; Stone et al.,
2004; Nolan et al., 1981). Treatment with Fe has led to inconclusive
results, in some cases causing an increase in reactivity, in others no
change and in some cases a reduction in toxicity (Cullen et al., 1997;
Fubini et al., 1995). In mixed dusts containing crystalline silica, such as
volcanic ash or coalmine dust, the presence of other mineral and
amorphous phases can occlude the silica particle surface (Donaldson
and Borm, 1998; Ghiazza et al., 2009; Horwell et al., 2012; Tourmann
and Kaufmann, 1994), and may also interact with the silica surface, as
clay extracts have been shown to dampen quartz toxicity (Stone et al.,
2004).
Due to confounding factors, such as the presence of other mineral
particles and variations in particle size and surface area within and
among samples, the role of structural substitutions in controlling the
toxicity of cristobalite dusts has not yet been determined. It is important
to establish whether the structural makeup of cristobalite is capable of
inﬂuencing its pathogenic potential so that these data can be taken into
account in risk assessment, and, eventually, exposure regulations in
cristobalite industries. Therefore, the aim of this study was to determine
if structural impurities in cristobalite can alter its toxic potential. Rather
than comparing a range of natural samples of uncontrolled composi-
tion, we instead assessed the in vitro toxicity of synthetic cristobalite
samples with structural impurities introduced by systematic doping
with incremental amounts of Al, with and without Na.
2. Materials and methods
2.1. Materials
Crystalline silica with and without impurities was produced using a
silica sol-gel method adapted from Chao and Lu (2002b). Colloidal si-
lica sol (Ludox TM-40, Sigma Aldrich) was dried at 120 °C for at least
12 h, in its pure form, or with dopants added. Samples were doped with
Al and Na nitrates in equivalent concentrations of 1, 2 and 3 wt% Al2O3
in a 1:1 M ratio of Al to Na, while accounting for the Al and Na already
in the silica sol, as measured by X-ray ﬂuorescence (XRF; data in Ad-
ditional ﬁle 1). The concentration range was deﬁned in order to un-
derstand the eﬀect of sequentially increasing Al and Na impurity con-
tents, in accordance with abundances observed in natural cristobalite
(Horwell et al., 2012). One Al-only doped sample was also produced to
constrain the role of Al, where only 3 wt% Al2O3 (and no additional Na)
was added to the starting material.
The resultant dried cakes were gently ground by hand and 5 g
pressed into 32 mm diameter pellets at a pressure of 120 MPa, using a
uniaxial press. Pellets were then heated at 1100 °C in a Carbolite hor-
izontal tube furnace (Durham University; Table 1) at a rate of 4.4 °C/
min and held at the target temperature for 24 h, before being cooled at
the rate of the furnace. Synthesis experiments could not be conducted in
the cristobalite stability ﬁeld (> 1470 °C (Deer et al., 2013)) because
doped samples treated at> 1300 °C melted, due to the decreased eu-
tectic temperature imparted by the impurities. Therefore, a synthesis
temperature of 1100 °C was selected as it is partway between the
melting temperature and the upper limit of quartz stability (870 °C
(Deer et al., 2013)). Further, naturally-occurring and industrial cristo-
balites are produced metastabily at, or below, this temperature in the
exposure settings of interest, such as the diatomaceous earth industry
and volcanic environments (Horwell et al., 2013; Engh, 2000), and this
temperature was appropriate, therefore, from both experimental and
exposure perspectives.
Table 1
Sample production conditions (treatment temperature, time, dopant concentrations), and
sample mineralogy (XRD and SEM-EDS).
Sample
name
Furnace conditions Dopants
added (oxide
wt%)
Minerals
(trace)*
Temp (°C) Time (h) Al Na
Non-doped 1600_12 1600 12 0.0 0.0 Cristobalite
1600_4 1600 4 0.0 0.0 Cristobalite
1100_24 1100 24 0.0 0.0 Tridymite,
(cristobalite)
Doped 2Al+Na 1100 24 1.0 0.6 Cristobalite,
(albite, ?)
3Al+Na 1100 24 2.0 1.2 Cristobalite,
albite, ?
5Al+Na 1100 24 3.0 1.8 Cristobalite,
albite, ?
3Al 1100 24 3.0 0.0 Cristobalite,
(albite, ?)
Raw materials SS – – 0.0 0.0 –
5Al
+Na_SS
– – 3.0 1.8 –
? represents unidentiﬁed phase.
* Phases in parentheses were only observed in trace quantities.
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For comparison, non-doped pellets were also heated for 4 or 12 h at
1600 °C (Table 1), above the tridymite-cristobalite transition tempera-
ture (Deer et al., 2013), to produce a non-doped cristobalite with a level
of crystallinity more similar to the doped samples (Table 2) and a
highly-crystalline non-doped cristobalite, respectively. The starting
material (silica sol; SS), dried at 120 °C and ground by hand, with 5 wt
% total Al+Na (5Al+Na_SS) and without dopants, were also tested pre-
crystallisation, as non-crystalline material controls. Samples and their
preparation conditions are presented in Table 1.
A slice of each pellet was mounted as polished resin blocks and
coated with 16 nm carbon for analysis by electron microprobe analyzer
(EMPA). The rest of each pellet was crushed with an agate pestle and
mortar and then ground in a cryogenic mill (to avoid any impact of
sample heating on crystallinity) in air at 12 cycles per second for
30 min, to produce a powder. Toxicological assays were conducted on
the milled material which was not further chemically digested to isolate
the cristobalite, as this is known to alter the crystalline silica surface
and reactivity (Fubini, 1998).
2.2. Particle characterisation
The mineralogy of the samples was determined by X-ray diﬀraction
(XRD) using a Bruker AXS D8 ADVANCE with DAVINCI design (Durham
University). Sub-samples of the cryogenically-milled pellets were fur-
ther ground, using an agate pestle and mortar, sieved onto silicon discs
to ensure random orientation, and identiﬁcation of phases was per-
formed using a locked-coupled scan from 2 to 90° 2θ with an 8 h scan
time. Mineral identiﬁcation was performed by comparison with library
patterns (ICDD, 2015). Ground samples were also compacted into a
deep well mount using the knife-edge of a spatula to ensure random
crystal orientation (Batchelder and Cressey, 1998). A run was then
performed using a ﬁxed parallel beam (6° θ) and a moving detector to
cover the range 18–35° 2θ, allowing the abundance of cristobalite to be
determined by peak-area measurements of the primary cristobalite peak
(~21.8° 2θ), and accurate measurements of primary cristobalite peak
position (an indicator of crystal purity (Damby et al., 2014)) to be
obtained.
The chemical composition of cristobalite was measured on cross
sections of a sub-sample of each pre-ground pellet by EMPA, using a
Cameca SX100 (Ludwig Maximilian University of Munich). A voltage of
15 kV and current of 4 nA was applied to measure Na, Al and Si con-
centrations. For Fe, Mg, K and S (present in the resin) concentrations, a
40 nA current was used (see Additional ﬁle 1). Areas for analysis were
selected by the characteristic cracking indicative of cristobalite at room
temperature that has undergone the β to α transition (Carpenter et al.,
1998). Backscatter imaging by scanning electron microscopy (SEM) and
energy dispersive X-ray spectroscopy (EDS) mapping was also per-
formed, at 15 kV (Hitachi SU-70 FEG SEM, Durham University), to
identify chemically-distinct phases in the sectioned pellet.
Particle size distributions were analysed by laser diﬀraction using a
Coulter LS analyser (Durham University), with polarization intensity
diﬀerentiation scattering (PIDS). Particles were suspended in water
until an obscuration value of 8–12% was acquired, and sonicated for
120 s prior to analysis. Data were analysed by Fraunhofer theory and
are presented as the cumulative volume %, volume % and median
diameter. Particle size was also qualitatively assessed by SEM imaging
using a Hitachi SU-70 FEG-SEM with a voltage of 8 kV (Durham
University).
Speciﬁc surface area was analysed by nitrogen adsorption mea-
surements at 77 K using a TriStar 3000 instrument (Durham
University). Samples were dried in nitrogen gas at 120 °C overnight.
The Brunauer-Emmett-Teller (BET) theory was applied to measure-
ments at relative pressures of 0.05–0.24, and the results are the mean of
three repeated measurements.
Zeta potential measurements were performed to determine particle
surface charge, which has been shown to be an important factor in the
cytotoxicity of silica nanoparticles to keratinocytes (Park et al., 2013).
Samples at 62.5 µg/ml in complete medium (RPMI medium, containing
10 μl/ml L-glutamine, 10 μl/ml penicillin and streptomycin, and 10%
foetal bovine serum, pH 7) were sonicated for 20 min and the zeta
potential measured using a Malvern Nanosizer (Heriot Watt Uni-
versity).
2.3. Toxicology
Cytotoxicity of the samples towards J774 macrophages was mea-
sured using the alamarBlue® and WST-1 assays (both a measure of
metabolic capacity), and the lactate dehydrogenase (LDH; a measure of
cell membrane damage) assay. Macrophages were chosen as they are
phagocytes and are actively involved in particle clearance from the
lung. Toxicity to these cells will result in reduced clearance and,
therefore, potential biopersistence of insoluble particles. Further, sub-
lethal activation can promote inﬂammation. Therefore, macrophages
play a key role in the physiological and pathophysiological responses to
inhaled particles, and use of well-established model cell lines, like J774,
allows for testing of this response. Samples were suspended in complete
medium and sonicated for 20 min at 37 °C at 50–50 Hz (Ultrawave Q;
Heriot Watt University). J774 macrophages were seeded in a 96 well
plate (5 × 104 cells per well) and exposed to 100 μl of particle sus-
pension in concentrations of 8, 16, 31, 62, 125, 250, and 500 μg/ml for
24 h or 48 h at 37 °C and 5% CO2. Following exposure, the supernatant
was removed and stored at −80 °C for LDH and cytokine analysis. For
the alamarBlue® assay, a solution of 1 mg/ml alamarBlue® reagent
(resazurin sodium salt; Sigma) in saline was diluted 1:10 in complete
medium and 100 μl added to the cells. The plate was incubated for 4 h
and ﬂuorescence measured with excitation at 560 nm and emission at
590 nm. For the WST-1 assay, cells were exposed to sample treatments
in the same way for 24 h, the supernatant was removed from the cells
and 100 μl WST-1 (tetrazolium salt; Roche), diluted 1:10 in complete
medium, was added to each well. Cells were incubated for 3 h and the
Table 2
Cristobalite abundance, cristobalite primary XRD peak position, and cristobalite chemistry of samples.
Samples Cristobalite abundance (%± s.d.) Cristobalite primary peak position (° 2θ±s.d.) Cristobalite chemistry (wt%± s.d.)
SiO2 Al2O3 Na2O
Non-doped 1600_12 92±4 21.95± 0.02 99.9±0.4 0.0± 0.0 0.1± 0.1
1600_4 87± 8 21.96± 0.04 99.6±0.4 0.0± 0.0 0.1± 0.1
1100_24 NA NA NA NA NA
Doped 2Al+Na 88±9 21.94± 0.03 98.4±0.7 0.7± 0.3 0.5± 0.2
3Al+Na 64±9 21.89± 0.04 97.6±1.1 1.4± 0.7 0.8± 0.4
5Al+Na 63±20 21.79± 0.03 95.9±2.0 2.5± 1.2 1.4± 0.6
3Al 59± 3 21.87± 0.05 NA NA NA
Cristobalite abundance (peak area by XRD (n = 2)), cristobalite primary XRD peak position (n = 2; indicative of structural impurities), and cristobalite chemistry (EMPA (n> 30)). s.d.
= one standard deviation; NA = not analyzed. Raw materials contained no cristobalite so data are not included in the Table.
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absorbance measured at 450 nm. LDH release from macrophages was
measured by adding 10 μl of cell supernatant to 50 μl 1 mg/ml NADH in
0.75 mM sodium pyruvate, incubating for 30 min at 37 °C in 5% CO2,
adding 50 μl of 2 mg/ml 2,4-dinitrophenylhydrazine in 1 M HCl and
incubating for 20 min at room temperature in the dark, before adding
50 μl 4 M sodium hydroxide and measuring the absorbance at 550 nm.
Imaging of untreated and particle-treated cells post-24 h exposure was
performed using light microscopy to qualitatively assess particle uptake
and cell viability.
Leachate solutions were also assessed by the alamarBlue® assay, to
constrain the contribution of soluble components to observed re-
activity. Particle suspensions at 500 µg/ml (the top concentration
tested) in complete medium were incubated for 24 h and centrifuged at
10,000×g for 10 min to remove particles. The leachate was then used
in the alamarBlue® assay at 24 h exposure.
Tumour necrosis factor alpha (TNF-α) was measured as a marker of
inﬂammation, as TNF-α is a pro-inﬂammatory cytokine associated with
silica-induced toxicity (Mossman and Glenn, 2013; Piguet et al., 1990).
TNF-α was measured in the supernatant of cell cultures treated with
125, 62, or 16 µg/ml of the samples for 4 and 24 h, to capture initial
TNF-α production, and levels at the ﬁrst time point of measured cyto-
toxicity, respectively, using BD™ Cytometric Bead Array cytokine ﬂex
sets (BD Biosciences) according to the manufacturer's instructions.
Haemolysis was used to measure the ability of particles to rupture
cell membranes, and has been shown to be a good indicator of the pro-
inﬂammatory potential of crystalline silica (Pavan et al., 2014). A vo-
lume of 1 ml of sheep blood in Alsever's solution (Oxoid Ltd.) was
centrifuged at 2348 × g for 2 min and the supernatant removed. Iso-
lated red blood cells were washed three times with saline and 100 μl of
cells were added to 3.6 ml saline. Particle suspensions of 1 mg/ml
particles in saline were sonicated for 20 min, serially diluted to ﬁnal
concentrations of 1000, 500, 250, 125 and 62 μg/ml, and 150 μl of the
particle suspensions added to 96 well plates in triplicate. Next, 75 μl of
the prepared blood was added to each well, the plate covered and
placed on an orbital shaker for 1 h. Post-exposure, the plate was cen-
trifuged at 250 × g for 5 min, 100 μl of the supernatant was transferred
to a new plate and absorbance measured at 540 nm.
In all assays, 0.5% Triton-X in either complete medium or saline was
used as a positive control and untreated cells as a negative control.
DQ12, a quartz sand with high toxic potency and<5 µm in diameter,
was used as a high-toxicity crystalline silica standard and TiO2
(Degussa; 25 nm particle size) as a low-toxicity particle standard.
2.4. Statistical analyses
ANOVA general linear model with a Tukey's post-hoc test was per-
formed to determine the signiﬁcance of diﬀerences among samples in
the in vitro assays (Minitab 15; * p<0.05, ** p<0.01, *** p<0.001).
3. Results
3.1. Particle characterisation
Cristobalite constituted ~90% of both the non-doped samples he-
ated at 1600 °C (1600_12 and 1600_4) and the doped sample 2Al+Na,
while cristobalite contributed ~60% of samples doped with> 3 oxide
wt% Al or Al+Na (Table 1 and Table 2). The non-doped sample heated
at 1100 °C (1100_24) contained substantial quantities of tridymite
(another crystalline silica polymorph), and cristobalite content could
not be determined due to peak overlap in the XRD patterns (Table 1).
By SEM, the sample appeared to be predominantly tridymite, as it did
not contain the characteristic cracking of cristobalite. Elemental ana-
lysis by electron microprobe on selected cristobalite areas showed that
the Al and Na content in cristobalite increased as the amount of dopant
was increased (Table 2). A shift in the cristobalite primary XRD peak
towards lower 2θ values as dopant concentration increased was ob-
served (Table 2). This is indicative of increased d-spacing (a measure of
the unit cell size in the crystal), which has been attributed to the pre-
sence of impurities within the crystal structure (Damby et al., 2014).
Albite (NaAlSi3O8), a feldspar, was observed in small amounts in the
XRD patterns of 3Al+Na, 5Al+Na, and in trace quantities in 2Al+Na
and 3Al, as these were only detected in long duration XRD scans. Other
Al- and Na-rich crystals, enriched in Si compared to albite but otherwise
similar in chemistry, were observed in all Al+Na doped samples by
SEM-EDS (Fig. 1) but were not detected by XRD and could not be
identiﬁed. Albite or Al- and Na-rich minerals were not detected in non-
doped samples (Fig. 1b). Amorphous material constituted the re-
mainder of each sample, and amorphous content was greater in doped
samples compared to non-doped samples.
For particles generated for the toxicological assays, by volume %,
Fig. 1. Backscatter images and chemical compo-
sition maps of sectioned samples. Chemical com-
position maps (blue = Si, red = O, yellow = Na,
green = Al) measured by energy dispersive X-ray
spectroscopy (EDS) of sectioned a-b) non-doped
1600_12 and c-d) doped 5Al+Na samples. A = al-
bite, ? = unidentiﬁed Al- and Na-rich silicate. (For
interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of
this article.)
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median particle diameter was between 5 and 7 µm for milled, doped
samples and 1600_4 (Table 3). The other non-doped samples were
slightly coarser, on average, with median diameters between 9 and
13 µm. All samples had>90% particles< 30 µm in diameter (Fig. 2a),
and had a bi- or multi-modal distribution (Fig. 2b). By SEM imaging,
few particles were observed that were> 5 µm, indicating that, by
number %, most particles were ﬁner than the median indicated by laser
diﬀraction (Fig. 3). Samples were suﬃciently ﬁne-grained for successful
phagocytosis (Fig. 7).
Speciﬁc surface area ranged from 1 to 5 m2/g in the synthesised
samples, and was at least 19 times higher in the starting materials
(Table 3). Surface charge of particles suspended in complete medium
was between −9.5 and −11.4 mV for all samples and standards
(Table 3).
3.2. In vitro toxicology assays
Cell viability was assessed using the alamarBlue®, WST-1 and LDH
assays. Cell viability of J774 macrophages, measured by the
alamarBlue® assay was sensitive to the positive control DQ12 quartz
and not to the negative control TiO2. A mixture of cytotoxicity results
were observed for the non-doped samples, with 1100_24 and 1600_12
demonstrating signiﬁcant decreases in viability at 24 h at the highest
concentration tested (500 µg/ml), while 1600_4 did not. In addition,
the cell viability at 48 h was signiﬁcantly lower than 24 h for both non-
doped 1600_4 and 1100_24, suggesting a time-dependent increase in
toxicity. In contrast no signiﬁcant toxicity was observed in the
alamarBlue® assay for any doped samples at either time point or at any
concentration compared to the control (Fig. 4). A small decrease in cell
viability was observed at 48 h compared to 24 h for cells treated with
3Al doped sample (Fig. 4), but this eﬀect is so small it is of little phy-
siological relevance. Leachates and the starting materials (SS and 5Al
+Na_SS) did not induce cytotoxicity in the J774 cells according to the
alamarBlue® assay (data in Additional ﬁle 1).
Cell viability, measured by the WST-1 assay, generated unreliable
data, possibly due to particle interference, and so are not presented.
The assessment of membrane damage via the LDH assay was per-
formed after a 24 h exposure. Firstly, the positive control DQ12 induced
signiﬁcant cytotoxicity, while the negative control TiO2 did not (Fig. 5).
All synthesised samples induced a dose-dependent increase in LDH re-
lease. All three non-doped samples reached signiﬁcant LDH release at
concentrations of 250 µg/ml and higher (Fig. 5). In addition, the sample
doped with 2Al+Na also displayed increased LDH release at exposure
concentrations of 250 µg/ml and higher. In contrast, samples doped
with 3Al, 3Al+Na or 5Al+Na only reached signiﬁcant LDH release at
exposure concentrations of 500 µg/ml. The data suggest that the 3Al
doped sample was the least cytotoxic according to the LDH assay but,
due to data variability, the eﬀect of 3Al doped cristobalite was not
statistically diﬀerent from the other doped samples.
For the assessment of pro-inﬂammatory mediator production, the
positive control DQ12 induced a dose-dependent increase in TNF-α
production, while the negative control TiO2 had no signiﬁcant impact
(Fig. 6). For the synthesised, doped and non-doped samples, no sig-
niﬁcant induction in TNF-α production by treated cells was observed
compared to the untreated control at either 4 or 24 h exposure time
(Fig. 6).
Light microscopy imaging of treated cells showed potential cellular
uptake of particles from all samples, although it is possible particles
were adhered to cell surfaces (Fig. 7). Some particles were clearly not
engulfed, especially in cells treated with non-doped 1600_12 and
1100_24 samples.
Haemolysis is presented by mass and surface area dose (Fig. 8). As
haemolysis is the direct interaction between the cell surface and par-
ticle surface it is appropriate to present the data as surface area dose,
due to the variable surface area of the samples (Table 3). Firstly, DQ12,
the positive control, induced dose-dependent haemolysis, while the
negative control, TiO2, had no signiﬁcant eﬀect. Sample-induced hae-
molysis was dose-dependent for all samples, except for those doped
with 3Al+Na and 3Al, which were non-haemolytic at all concentra-
tions tested (Fig. 8a). Non-doped 1100_24 was the most haemolytic
sample, producing a similar dose response to the DQ12 positive control.
By surface area dose, the data do not fall on to one line, suggesting
diﬀerences in the surface reactivity of the samples. The most potent
samples, when expressed as surface area dose, were the synthesised,
non-doped 1100_24 and the 1600_12. These were followed by DQ12
and the 2Al+Na doped sample which were almost identical, followed
closely by the 5Al+Na doped sample and the non-doped 1600_4. Again,
the 3Al+Na and 3Al doped samples did not induce a signiﬁcant hae-
molytic eﬀect when expressed as surface area dose (Fig. 8b).
Table 3
Physical characteristics and surface charge measurements of samples.
Sample Median particle
diameter
Surface area Surface charge
(µm) (m2/g) s.d. (mV) s.d.
Non-doped 1600_4 7.3 4.0 0.1 −11.4 0.8
1600_12 10.9 0.9 0.1 −9.8 1.1
1100_24 8.9 4.0 0.5 −11.1 0.6
Doped 2Al+Na 7.4 2.1 0.2 −9.8 0.8
3Al+Na 6.4 4.7 0.0 −10.7 1.1
5Al+Na 6.6 2.7 0.1 −10.0 0.8
3Al 6.0 4.9 0.2 −10.7 1.2
Raw materials SS NA 94.6 2.8 −9.5 0.8
5Al+Na_SS NA 87.0 0.8 −9.7 1.0
DQ12 NA 9.2 0.2 −10.5 0.8
TiO2 NA NA NA −9.8 1.4
Particle size (laser diﬀraction), surface area (BET) and surface charge in complete
medium (RPMI + 10% foetal bovine serum + antibiotics; zeta potential) for non-doped
and doped samples, starting material and standards. s.d. = one standard deviation. NA=
not analyzed.
Fig. 2. Particle size distributions of crystalline silica samples. Particle size distribu-
tions of cryogenically-milled doped and non-doped crystalline silica samples measured by
laser diﬀraction and presented as a) cumulative volume %, and b) volume %.
C. Nattrass et al. Environmental Research 159 (2017) 164–175
168
4. Discussion
Chemical impurities have been identiﬁed as one potential factor
which may aﬀect the variable toxicity of crystalline silica (Donaldson
and Borm, 1998). It has been hypothesised that structural Al impurities
may have a similar dampening eﬀect on the toxicity of naturally-impure
cristobalite, such as that found in volcanic ash and processed diato-
maceous earth (Horwell et al., 2012; Nattrass et al., 2015). However, no
study, to date, has measured the eﬀect of Al substitutions on cristobalite
toxicity, directly. Here, the in vitro toxicity of cristobalite, synthesised
to systematically vary concentrations of Al and Na dopants, was eval-
uated to determine whether chemical impurities can alter reactivity.
4.1. The eﬀect of doping on crystalline silica toxicity in vitro
In general, when treating the J774 cell line in vitro, doping
appeared to dampen cytotoxicity of the synthetic samples. This was
most apparent in the LDH assay, and supported by the alamarBlue®
assay, where only non-doped samples 1100_24 and 1600_12 elicited a
signiﬁcant cytotoxic response. The Al-only (3Al) doping seemed to be
the most eﬀective at preventing cytotoxicity in vitro, however, the
diﬀerence between 3Al and the co-doped (Al+Na) samples was not
statistically signiﬁcant.
The magnitude of cytotoxicity varied by assay. The diﬀerence in
sensitivity may be due to the nature of the endpoints which include a
measure of metabolic capacity (alamarBlue® assay) versus a measure of
membrane leakage (LDH assay), suggesting that membrane leakage
could be occurring in cells where metabolic capacity is not suppressed.
In both assays, the high-toxicity particle control (DQ12) gave a con-
centration-response relationship, as expected, and the low-toxicity
particle control (TiO2) had low toxicity, as expected, suggesting both
assays were performed successfully. Interference of the particles in the
Fig. 3. Representative scanning electron microscopy
images of synthetic crystalline silica particles.
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WST-1 assay, strengthens the argument for the use of multiple assays to
assess cytotoxicity within a study of this type.
The haemolysis results also demonstrated diﬀerences among the
potencies of the particles. The similarity in potency of the non-doped
1100_24 compared to the DQ12 positive control was clear when ex-
pressed as a mass dose, whereas doped samples (also produced at
1100 °C) were more than 28% less haemolytic at the top dose tested.
Modifying the dose to the surface area metric suggested that the toxicity
of 1600_12 sample, as well as 1100_24, was relatively high compared to
DQ12, suggesting a more reactive particle surface than doped samples.
In fact, doping with Al‐only (3Al) eliminated the haemolytic potential
altogether, supporting the hypothesis that doping decreased the hae-
molytic potential of the samples.
Regardless of the magnitude of toxicity, the same trend was ob-
served in all assays: doping generally dampened particle reactivity. The
potential mechanisms for this eﬀect are now discussed.
4.2. Mechanisms of doping-induced suppression of crystalline silica toxicity
A primary mechanism by which doping likely reduces the toxicity of
crystalline silica is by alteration of the particle surface which, in an
insoluble particle, interacts with cells directly. Here, doping caused
substantial changes in crystal chemistry through structural substitu-
tions, aﬀected crystalline silica abundance, degree of crystallinity and
the polymorph formed, all of which can alter the particle surface
properties, and, therefore, bioreactivity.
4.2.1. Chemical substitutions and structural impurities
The results of this study indicate that structural impurities in cris-
tobalite reduce cytotoxicity and haemolytic ability. The Al-only doped
sample (3Al) was consistently the least reactive (although not statisti-
cally diﬀerent from samples doped with>3 oxide wt% Al+Na) and,
importantly, was the only doped sample (with>3 oxide wt% dopant)
not to have formed accessory minerals such as albite, the presence of
which may inﬂuence toxicity (discussed below). It also had a similar
cristobalite content to Al+Na doped samples. Therefore, there is strong
evidence to suggest that the reduced cytotoxicity and haemolytic po-
tential is caused by the addition of Al to the crystal structure, in-
corporation of which is evidenced by the shifted cristobalite XRD pri-
mary peak position compared to non-doped cristobalite.
Similarly, it is likely that the incorporation of elements into the
cristobalite structure in co-doped samples also dampened their ability
to induce cytotoxicity, although the presence of albite and reduced
cristobalite content, compared to non-doped samples, may also have
contributed to a decrease in toxicity (see below). Cristobalite in co-
doped samples contained between 1 and 4 oxide wt% Al+Na, where
the Al+Na content in cristobalite increased with increased doping. No
reduction in cytotoxicity was observed for samples doped with 2 oxide
wt% Al+Na, which corresponds with< 1 oxide wt% Al in its structure,
compared to non-doped samples. However, samples doped with>3
oxide wt% Al+Na (> 1.4 oxide wt% Al in their structure) had dimin-
ished cytotoxicity. Therefore, we see an empirical threshold of ~1 oxide
wt% Al in the cristobalite structure, above which cristobalite cyto-
toxicity is reduced for these synthetic samples. This same trend was not
seen for the haemolytic potential of the samples, where the amount of
dopant does not appear to inﬂuence the extent of haemolysis in Al+Na
Fig. 4. Cell viability of J774 macrophages treated with crystalline silica samples
measured by the alamarBlue® assay. Cell viability compared to an untreated control of
J774 macrophages treated with 500 µg/ml non-doped samples (white), doped samples
(grey), and standards (black) for 24 h (solid) or 48 h (striped). Error bars represent
standard error (n = 4). * p =<0.05 diﬀerence from untreated control, brackets indicate
signiﬁcant diﬀerences between exposure for 24 or 48 h.
Fig. 5. Cytotoxicity of crystalline silica samples to J774 macrophages measured by
the LDH assay. LDH release as a percentage of a positive (Triton-X) and untreated control
for J774 macrophages treated with 125–500 µg/ml sample concentrations for 24 h. Error
bars represent standard error (n = 4). ** p =<0.01, *** p =<0.001 diﬀerence from
untreated control.
Fig. 6. TNF-α production by J774 macrophages exposed to crystalline silica sam-
ples. Exposures to concentrations of 16–125 µg/ml sample suspensions for a) 4, and b)
24 h. Error bars represent standard error (n = 3). ** p =<0.01 diﬀerence from un-
treated control.
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doped samples, suggesting similar surface chemistry among these
samples.
Elements incorporated structurally will be present at the surface of
the particle, as well as internally. Al treatment of the quartz surface
decreases its cytotoxic potency, ability to induce inﬂammatory in-
dicators, and its haemolytic potency (Duﬃn et al., 2001; Nolan et al.,
1981). It has been suggested that an Al treatment would bind to silanols
(a surface functional group with the connectivity Si–O–H) on the silica
surface, replacing H+ and, thereby, prevent the adsorption of cell
membrane components to the silica surface (Fubini, 1998). Pavan et al.
(Pavan et al., 2013, 2014; Pavan and Fubini, 2016) have shown that the
distribution of silanols on the silica surface aﬀects its haemolytic and
inﬂammatory potency, and Turci et al. (2016) have also shown that the
silanol distributions on fractured crystal faces are a key factor in
Fig. 7. Light microscopy images of J774 macro-
phages post-24 h treatment with 500 µg/ml
samples. a) untreated cells, b-c) non-doped cristo-
balite, d) non-doped tridymite, e) DQ12 quartz, f-i)
doped cristobalite, and j) TiO2 (× 32 magniﬁcation).
In c, d and e, particles that have not been engulfed
are present.
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membrane damage. Therefore, structural substitution of Al for Si ions
would alter the distribution and abundance of these silanols, aﬀecting
the silica surface-cell interactions and, therefore, haemolytic potential
and cytotoxicity, as seen here.
It is possible that, as structural impurities were seen throughout the
cristobalite crystals, and the ameliorating eﬀect on cristobalite cyto-
toxicity was sustained up to 48 h, the eﬀect of impurities here will be
long-term. However, in vivo studies would be needed to conﬁrm if the
ameliorating eﬀect of Al impurities can be sustained in the lung.
The data suggest that co-doping with Al+Na might be less eﬀective
at decreasing cytotoxicity or haemolytic potential compared to Al-only
doping. We hypothesise that Na in the structure may somehow hinder
the ability of Al to suppress reactivity. The mechanism behind this
should be the focus of future work, as the presence of both Al and Na is
more representative of natural or industrially-occurring cristobalite.
However, the explanation may lie in the presence and eﬀect of the
accessory minerals in the co-doped samples (discussed below) and it
will be challenging to separate the two eﬀects as, in this study, we were
unable to grow only cristobalite in co-doped samples (of> 2 wt% Al
+Na).
4.2.2. Presence of other mineral phases
The presence of other mineral phases was not anticipated here, but
has been considered to have an ameliorating eﬀect on crystalline silica
toxicity in mixed dusts, such as diatomaceous earth, volcanic ash and
coalmine dust, by altering or masking the surface of the crystalline si-
lica or by interacting with the silica particle once inhaled (Donaldson
and Borm, 1998; Ghiazza et al., 2009; Horwell et al., 2012; Nattrass
et al., 2015). Therefore, the presence of Al and Na-rich phases (albite
and an unidentiﬁed Al- and Na-rich phase) may also have impacted the
toxicity of cristobalite, here. Feldspars are generally considered to have
low toxicity (e.g., Housley et al., 2002) so it is unlikely that albite
would contribute to the toxicity of these samples, but it may have
masked the surface of the crystalline silica (if still adhered to the cris-
tobalite after pulverisation), thereby reducing its toxic potency. How-
ever, as albite was observed in Al+Na doped samples but was barely
detected in the Al-only doped sample and, as discussed, the Al-only
doped sample was the least reactive, it cannot be the sole cause for the
decreased reactivity of doped samples.
4.2.3. Crystalline silica polymorph and abundance
Doping caused variation in the crystalline silica polymorph pro-
duced under the same treatment conditions; the non-doped sample
heated to 1100 °C produced predominantly tridymite (1100_24),
whereas doped samples treated at that temperature produced cristo-
balite. This was expected because synthesis was undertaken within the
tridymite stability ﬁeld (Deer et al., 2013), but was considered an im-
portant comparison nonetheless. Studies of tridymite toxicity are lim-
ited, but its toxic potential has been suggested to be similar to cristo-
balite, based on their similar structure (Smith, 1998). This hypothesis is
supported by Marks et al. (1956), who showed no diﬀerence between
cristobalite and tridymite toxicity towards guinea pig cells in vitro.
However, intratracheally-injected tridymite into rats was shown to be
more potent at initiating ﬁbrosis than quartz or cristobalite (King et al.,
1953). This suggests that tridymite toxicity is variable, as with quartz
and cristobalite, and is in agreement with a study by Mossman and
Glenn (2013), which showed no diﬀerence, overall, between the pa-
thogenicity of cristobalite and quartz. This suggests that surface prop-
erties of the particles are more important than the silica polymorph in
determining toxicity.
In the present study, non-doped 1100_24 (tridymite) had a similar
cytotoxic capacity to the non-doped cristobalites, and a similar hae-
molytic capacity to 1600_12 (non-doped cristobalite) based on surface
area dose, suggesting similar surface reactivity between the poly-
morphs. However, by mass, 1100_24 was signiﬁcantly more haemolytic
than either the non-doped or doped cristobalite samples.
Lower cristobalite abundance was observed in the doped cristobalite
samples (Table 2) compared to non-doped cristobalite. As tridymite was
formed at the same treatment conditions as doped cristobalite samples
(heated at 1100 °C for 24 h), it is not possible to compare crystal
abundance directly between non-doped and doped samples, and it is
unclear whether the reduction in crystal abundance in doped cristo-
balite samples compared to non-doped cristobalite (formed at 1600 °C)
is due to the addition of dopants, or diﬀerences in production condi-
tions. However, previous studies show that doping with Na (Chao and
Lu, 2000) or Al (Chao and Lu, 2002a) can decrease cristobalite abun-
dance, therefore, it is likely that doping resulted in the decreased
abundance seen in doped samples here.
It is likely that the lower cristobalite abundance in doped samples
contributed to their decreased cytotoxicity compared to non-doped
samples. Indeed, the three samples with ~90% cristobalite (1600_4,
1600_12 and 2Al+Na) were more cytotoxic than the three samples
containing ~60% cristobalite (3Al+Na, 5Al+Na and 3Al). However,
haemolytic potential did not correlate with cristobalite abundance, and
the greater reduction in reactivity of the Al-only sample (3Al) in both
the haemolysis and LDH assays compared with the>3 oxide wt% Al
+Na doped samples, all of which contained ~60% cristobalite, high-
lights a dependence on additional characteristics beyond crystal
abundance, as discussed above.
4.3. The eﬀect of doping on particle uptake
Al lactate treatment has been shown to decrease particle uptake by
epithelial cells (Schins et al., 2002). The J774 macrophages used in the
present study are considered professional phagocytes, and particle
Fig. 8. Haemolytic potential of crystalline silica samples to sheep red blood cells.
Haemolysis as a percentage of a positive (Triton X) and untreated control for red blood
cells treated with 62–1000 µg/ml sample concentrations for 1 h, presented by a) mass
dose, and b) surface area dose. Error bars represent standard error (n = 4). ** p =<0.01
diﬀerence from untreated control.
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uptake, therefore, diﬀers from epithelial cells. Nonetheless, some par-
ticles were not engulfed by cells and this was most-commonly observed
in cells treated with non-doped samples. The uptake technique used was
not quantitative, however, and could be inﬂuenced by diﬀerences in the
ability to visualise the diﬀerent particle types by light microscopy (e.g.,
due to agglomeration). The similar zeta potential for all samples,
standards and starting materials is possibly due to coating of the par-
ticles with proteins, as foetal bovine serum is included in the complete
medium. This coating means that particle uptake is likely not aﬀected
by particle charge, however, once engulfed, this coating may be broken
down and the presence of Al and Na at the surface of doped samples
may then aﬀect particle reactivity in the cell. Therefore, unlike the
aforementioned study using epithelial cells, the observation of particles
that were not engulfed by macrophages could be attributed to release
from dead cells. Since cytotoxicity was greater for the non-doped
samples, this might explain why these particles could be visualised
more easily outside of cells.
4.4. The eﬀect of doping on pro-inﬂammatory mediators
TNF-α is involved in the pathway of silica pathogenicity (Piguet
et al., 1990). Al treatment of quartz has been shown to decrease its
ability to induce inﬂammatory cytokine (MIP-2) release, and prevent
quartz induction of NF-ĸB activation (Duﬃn et al., 2001), which can
lead to the inhibition of TNF-α production (Chen et al., 1995; Gozal
et al., 2002; Rojanasakul et al., 1999). However, in the present study,
the synthesised non-doped samples did not aﬀect TNF-α production.
The lack of TNF-α production in cells treated at sub-lethal concentra-
tions suggests that these samples do not have the ability to cause in-
ﬂammation via the TNF-α pathway previously observed for quartz
(Chen et al., 1995; Rojanasakul et al., 1999), and that TNF-α is not
involved in the observed cytotoxicity. Previously, Gozal et al. (2002)
showed that silica can induce apoptosis in cells with no increase in TNF-
α production. TNF-α production by macrophages, and by triple-cell co-
cultures including macrophages, has also been shown to be low in
cristobalite-rich diatomaceous earth samples (Nattrass et al., 2015), and
cristobalite-rich volcanic ash (Damby et al., 2015; Tomašek et al.,
2016).
4.5. Other factors aﬀecting reactivity
Median particle size did not vary much amongst the samples and
particle size distributions were similar for most samples, although non-
doped samples were slightly coarser, whereas surface area ranged from
1 to 5 m2/g in the crystallised samples. No correlation between surface
area and particle size was observed, possibly due to the presence of pore
spaces as, during heat treatment, water and N2 are removed, potentially
leaving pores (Fig. 1). Alternatively, as particle size is measured in
solution, it is possible that there was preferential aggregation of some
samples compared to others, although all samples were sonicated to try
to prevent aggregation. The bi- or multi-model particle size distribu-
tions are likely due to the presence of amorphous material, which has a
lower hardness and is more easily milled to smaller particle sizes than
crystalline material. Diﬀerences in surface area or particle size, alone,
do not explain diﬀerences in observed cytotoxicity or haemolytic po-
tential.
4.6. Implications for the toxicity of natural and industrial cristobalite and
regulation
Findings from this study suggest that modiﬁcation of cristobalite
through the introduction of structural impurities, can reduce reactivity
in comparison to pure cristobalite. The ﬁndings add weight to the hy-
pothesis, posed by Horwell et al. (2012) and Nattrass et al. (2015), that
the low reactivity of diatomaceous earth and volcanic cristobalite, in
vitro, is controlled by the presence of both ‘inherent characteristics’ and
‘external factors’, as suggested by the working group of the Interna-
tional Agency for Research on Cancer, in their recognition that crys-
talline silica can be variably hazardous (IARC, 1997).
Doping with Al, alone, has a relatively clear eﬀect in reducing the
potential toxicity of cristobalite, with additional Na impurities ap-
pearing to lessen that eﬀect. However, co-doping with Al+Na is more
representative of the composition of natural and industrial-related
cristobalite, which has never been observed to contain only Al (Horwell
et al., 2012; Nattrass et al., 2015).
That crystalline silica has variable toxicity is well established
(Donaldson and Borm, 1998). However, regulations, including occu-
pational exposure limits (OELs) or permissible exposure limits (PELs),
do not currently take into account this variability. Mostly, a single OEL
value is used for quartz and cristobalite although, sometimes, cristo-
balite is given a lower OEL (i.e. more stringent) than quartz (NIOSH,
2002). However, this is based on outdated understanding, and we
propose that the crystal purity and the purity of the dust, itself, in terms
of crystalline silica content, are extremely important in determining
potential toxicity. Therefore, it may be more appropriate to set OELs
based on knowledge of the characteristics of the crystalline silica in-
volved in the occupational exposure.
Further, hazard management responses to cristobalite exposure post
volcanic eruption may be impacted by this and future research. During
the 1995–2011 Soufrière Hills eruption, communities were frequently
exposed to cristobalite-rich volcanic ash (Horwell et al., 2014; Baxter
et al., 1999, 2014) in quantities exceeding the American Conference of
Government Industrial Hygienists’ OELs for cristobalite (Searl et al.,
2002). However, a quantitative risk assessment of the likelihood of
individuals developing silicosis showed that the ash could be regarded
as a ‘mixed dust’ of low to moderate toxicity (Hincks et al., 2006). In
future eruptions, we envisage that tailored environmental exposure
limits could be set, based upon a more robust knowledge of the struc-
ture-toxicity relationship for cristobalite-rich volcanic ash (Horwell
et al., 2012) in lieu of clinical studies on silicosis development, which
has never yet been documented in volcanic settings (Horwell and
Baxter, 2006).
5. Conclusions
Crystalline silica toxicity is variable and it has been hypothesised
that inherent and external impurities can both dampen and augment
cristobalite toxicity. Here, doping synthetic silica with Al or co-doping
with Al and Na, pre-crystallisation, led to an apparent decrease in
cristobalite cytotoxicity and haemolytic potential compared to non-
doped samples. The inhibition of cristobalite-induced reactivity by Al-
only doping was attributed to structurally-substituted Al. The decreased
toxicity of co-doped samples compared to non-doped samples was also
partially attributed to structural Al, however, the decrease in cristo-
balite abundance that resulted from co-doping as well as the presence of
other minor aluminosilicates (albite and an unidentiﬁed phase) in these
samples may also moderate this eﬀect. Neither non-doped nor doped
samples induced TNF-α production, therefore, the role of structural
impurities in inﬂammatory processes could not be discerned.
It has previously been hypothesised that Al and Na substitutions in
volcanic and diatomaceous earth cristobalite may dampen their toxicity
(Horwell et al., 2012; Nattrass et al., 2015). It is shown here that these
substitutions may reduce cristobalite toxicity and, therefore, are likely
to contribute to dampening the toxicity of cristobalite-rich mixed-phase
dusts. These ﬁndings have implications for the setting of occupational
and environmental exposure limits for crystalline silica, which cur-
rently do not account for inherent characteristics which may render
cristobalite dusts much less toxic than predicted by laboratory stan-
dards.
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